Show Summary Details
Page of

Malaria 

Chapter:
Malaria
Author(s):

Frank Sorvillo

, Shira Shafir

, and Benjamin Bristow

DOI:
10.1093/med/9780199661756.003.0215
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 September 2019

Malaria, a mosquito-borne protozoal infection, is a global public health problem of overwhelming proportions, exacting a huge toll in morbidity, mortality, disability, and economic costs. Yet, effective treatment and prevention and control approaches are available and include the use of artemisinin combination therapy, long-lasting insecticide-treated nets, indoor residual spraying of insecticides, and other vector control measures, as well as intermittent preventive therapy for pregnant women, infants, and children. Over the past decade renewed momentum and considerable additional resources have yielded progress towards reducing the burden of malaria; however, these gains have been uneven and the impact of malaria remains staggering. Moreover, drug resistance, including to artemisinin, inadequate surveillance, operational challenges, insecticide resistance, competing priorities, and the threat of flagging resolve and funding threaten the progress already made and underscore the challenges that remain. Long-term commitment of resources and sustained efforts using integrated approaches targeted to local conditions will be necessary if malaria control and elimination is to be realized.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.